See All Slides - tctmd.com

Slides

Presentation TCT 2012

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Presenter: Jeffrey Popma

October 22, 2012

Presentation TCT 2012

Retrograde Application of Autologous BM Cells: Phase 2 Study Results

Presenter: Amit Patel

October 22, 2012

Presentation TCT 2012

Allogenic Cells for Chronic Left Ventricular Dysfunction: The USA Experience and Beyond

Presenter: Emerson Perin

October 22, 2012

Presentation TCT 2012

“Direct” Aortic Access is Easier, Safer, and Should be the Preferred Access Alternative!

Presenter: Michael Reardon

October 22, 2012

Presentation TCT 2012

Pioneer and Interventional Perspectives

Presenter: Alain Cribier

October 22, 2012

Presentation TCT 2012

CTO Case Volumes and the Learning Curve: Insights from the European CTO Registry

Presenter: Carlo Di Mario

October 22, 2012

Presentation TCT 2012

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

Presenter: John Webb

October 22, 2012

Presentation TCT 2012

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro!

Presenter: Mehdi Shishehbor

October 22, 2012

Presentation TCT 2012

Hemodynamics and Interactive Calculations for Aortic Stenosis Using the "John Madden" Telestrator

Presenter: Tim Lapp

October 22, 2012

Presentation TCT 2012

Thrombectomy Devices: Alternatives, Tips and Tricks

Presenter: Petr Kala

October 22, 2012

Advertisement

Slides

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Retrograde Application of Autologous BM Cells: Phase 2 Study Results

Allogenic Cells for Chronic Left Ventricular Dysfunction: The USA Experience and Beyond

“Direct” Aortic Access is Easier, Safer, and Should be the Preferred Access Alternative!

Pioneer and Interventional Perspectives

CTO Case Volumes and the Learning Curve: Insights from the European CTO Registry

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro!

Hemodynamics and Interactive Calculations for Aortic Stenosis Using the "John Madden" Telestrator

Thrombectomy Devices: Alternatives, Tips and Tricks

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content